New York says it will prioritize non-White people
in distributing low supply of COVID-19 treatments

Empire State considers being a minority a health ‘risk factor’ due to ‘longstanding systemic health and social inequities’

The state of New York said it will prioritize non-White people in the distribution of COVID-19 treatments in short supply.

New York’s Department of Health released a document detailing its plan to distribute the treatments, such as monoclonal antibody treatment and antiviral pills.

The plan includes a section on eligibility for the scarce antiviral pills that people must meet to receive the treatment, including a line stating a person needs to have “a medical condition or other factors that increase their risk for severe illness.”

One such “risk factor” is being a race or ethnicity that is not White due to “longstanding systemic health and social inequities”

“Non-white race or Hispanic/Latino ethnicity should be considered a risk factor, as  longstanding systemic health and social inequities have contributed to an increased risk of severe illness and death from COVID-19,” the memo reads.

The Empire State’s plan received backlash online for discriminating based on ethnicity and skin color.


DONATE

NO ADVERTISING ON DAWGS BLOG- PAID FOR BY DONATIONS

$10.00